# AVENUE THERAPEUTICS INC (ATXI)

> Institutional ownership reported to the SEC as of Q4 2024, from Form 13F filings. Source: https://holderbook.com/stocks/ATXI/

- Reporting holders: 7
- Reported value: $385.3K
- Shares held by institutions: 192,628 of 1,911,633 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Ikarian Capital, LLC](https://holderbook.com/funds/1778253-ikarian-capital-llc/) | $280.0K | 140,000 | 0.0% | 1 |
| [BOOTHBAY FUND MANAGEMENT, LLC](https://holderbook.com/funds/1549230-boothbay-fund-management-llc/) | $82.2K | 41,089 | 0.0% | 1 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $15.8K | 7,920 | 0.0% | 3 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $6.2K | 3,096 | 0.0% | 3 |
| [WELLS FARGO & COMPANY/MN](https://holderbook.com/funds/72971-wells-fargo-company-mn/) | $1.0K | 500 | 0.0% | 3 |
| [BANK OF AMERICA CORP /DE/](https://holderbook.com/funds/70858-bank-of-america-corp-de/) | $28 | 14 | 0.0% | 3 |
| [SBI Securities Co., Ltd.](https://holderbook.com/funds/1851815-sbi-securities-co-ltd/) | $18 | 9 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2024 | 7 | $385.3K |
| Q3 2024 | 8 | $491.8K |
| Q2 2024 | 8 | $407.2K |
| Q1 2024 | 13 | $168.9K |
| Q4 2023 | 14 | $52.4K |
| Q3 2023 | 13 | $157.3K |
| Q2 2023 | 11 | $849.4K |
| Q1 2023 | 13 | $532.7K |
| Q4 2022 | 13 | $520.5K |
| Q3 2022 | 10 | $766.0K |
| Q2 2022 | 16 | $181.0K |
| Q1 2022 | 14 | $503.0K |